SB 1613 Hawaii Senate · 2025 Regular Session

RELATING TO CANNABIS.

Summary
Establishes the Hawaii Cannabis and Hemp Office within the Department of Commerce and Consumer Affairs to regulate all aspects of the cannabis plant. Beginning 1/1/2026, legalizes the personal adult use of cannabis. Establishes taxes on the retail sale of adult-use cannabis and the sale of medical cannabis. Adds new traffic offenses relating to the consumption or possession of marijuana or marijuana concentrate. Makes conforming amendments related to the legalization of personal adult use of cannabis. Beginning 1/1/2026, decriminalizes certain drug offenses related to marijuana and marijuana concentrate. Transfers the personnel and assets of the Department of Health and assets of the Department of Agriculture relating to cannabis to the Hawaii Cannabis and Hemp Office. Establishes various positions within state entities to regulate the personal adult use of cannabis. Appropriates funds. Effective 12/31/2050. (SD1)
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 23, 2025 Last action Feb 24, 2025
Maddy AI version diff · 1 comparison

What changed between versions

SB1613 SB1613_SD1 · 10 edits
MAJOR
This bill transforms Hawaii's cannabis framework from a medical-only system to a comprehensive regulatory model that includes adult-use legalization, hemp integration, and a unified oversight body. The changes establish the Hawaii Cannabis and Hemp Office as the central regulatory authority, legalize adult-use cannabis for adults 21 and older starting January 1, 2026, and create new tax structures and grant programs for social equity and public health initiatives.
Scope change
The bill expands scope from medical cannabis only to include adult-use cannabis and hemp under one unified regulatory framework, replacing the previous medical-only system with a dual-system program.
TIMELINE

Adult-use cannabis legalization delayed until January 1, 2026, with a six-month preparation period for regulatory agencies, law enforcement, and businesses.

FISCAL

Established the Hawaii Cannabis and Hemp Office with dedicated funding through a special fund, including subaccounts for social equity grants, public health/education, public safety, and hemp development.

DEFINITION

Created comprehensive definitions for adult-use cannabis, hemp, hemp products, and related terms to distinguish between medical, adult-use, and hemp categories.

ENFORCEMENT

Mandated that the new office prioritize public health and safety, with powers to investigate, seize, and prosecute illegal cannabis activities outside safe harbor protections.

REQUIREMENT

Requires all cannabis businesses to obtain licenses, pay taxes, and comply with seed-to-sale tracking, security measures, and advertising restrictions to prevent targeting minors.

Added requirements for child-resistant packaging, labeling standards, potency limits, and restrictions on advertising and marketing to protect minors.

Mandated background checks for all office employees and contractors, with specific provisions for expunged convictions and marijuana-related offenses.

ELIGIBILITY

Established social equity grant programs for applicants from disproportionately impacted areas, requiring 51% ownership by residents of such areas or employment of local residents.

SCOPE

Consolidated medical cannabis, adult-use cannabis, and hemp under one regulatory framework through the new Hawaii Cannabis and Hemp Office, replacing the previous separate systems.

TECHNICAL

Included detailed definitions for hemp products with THC limits of 0.3% or less, distinguishing industrial hemp from products intended for human consumption.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
10
Key actions
5
Committee
7
Feb 24, 2025
Upper · Passed
The committee on CPN/WAM has deleted the measure from decision making scheduled on 02-26-25 10:00AM; CR 211 & Videoconference.
upper
Feb 20, 2025
Upper · Passed
The committee(s) on CPN/WAM will hold a public decision making on 02-26-25 10:00AM; Conference Room 211 & Videoconference.
upper
Feb 14, 2025
Committee
Reported from HHS/JDC (Stand. Com. Rep. No. 658) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/WAM.
upper
Feb 13, 2025
Upper · Passed
The committee(s) on JDC recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in JDC were as follows: 3 Aye(s): Senator(s) Rhoads, Chang, San Buenaventura; Aye(s) with reservations: none ; 2 No(es): Senator(s) Gabbard, Awa; and 0 Excused: none.
upper
Feb 13, 2025
Upper · Passed
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 3 Aye(s): Senator(s) San Buenaventura, Hashimoto; Aye(s) with reservations: Senator(s) Aquino ; 1 No(es): Senator(s) Fevella; and 1 Excused: Senator(s) Keohokalole.
upper
Feb 10, 2025
Upper · Passed
The committee(s) on HHS/JDC has scheduled a public hearing on 02-13-25 9:30AM; CR 016 & Videoconference.
upper
Jan 27, 2025
Committee
Referred to HHS/JDC, CPN/WAM.
upper
Jan 23, 2025
Introduced
Introduced.
upper
1 primary · 1 co-sponsor

Sponsors